Bacterial detection of platelets: Current problems and possible resolutions

Transfusion Medicine Reviews

Volumn 19, Issue 4, 2005, Pages 259-272

  Blajchman, Morris A ^a   Beckers, Erik A M ^b   Dickmeiss, Ebbe ^b   Lin, Lilly ^b   Moore, Gillian ^b   Muylle, Ludo ^b  

^a MCMASTER UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; STEROID; THROMBOCYTE CONCENTRATE;

ANTIBIOTIC THERAPY; BACTERIAL FLORA; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BELGIUM; BLOOD BANK; BLOOD TRANSFUSION; CANADA; CONFERENCE PAPER; DENMARK; EPIDEMIOLOGICAL DATA; ERYTHROCYTE; HUMAN; INCIDENCE; INFECTION RISK; MEDICAL TECHNOLOGY; MONITORING; NETHERLANDS; NONHUMAN; OUTCOMES RESEARCH; RELIABILITY; RISK REDUCTION; SAFETY; SCREENING; SCREENING TEST; SENSITIVITY ANALYSIS; SEPSIS; STORAGE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; UNITED KINGDOM;

BACTERIA; BACTERIAL INFECTIONS; BLOOD PLATELETS; BLOOD PRESERVATION; CONGRESSES; DISINFECTION; DRUG CONTAMINATION; HUMANS; PLATELET TRANSFUSION; QUALITY CONTROL; SEPSIS; SOCIETIES, MEDICAL;

EID: 26244462802     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2005.05.002     Document Type: Conference Paper

References (27)

1. C.D. Hillyer, C.D. Josephson, and M.A. Blajchman Bacterial contamination of blood components: Risks, strategies, and regulation Hematology (American Society of Hematology Education Program) 2003 575 589
2. M. Goldman, K.E. Webert, and D.M. Arnold Proceedings of a Consensus Conference: Towards an understanding of TRALI Transfus. Med. Rev. 19 2005 2 31
3. D. Asher, C.L.J. Atterbury, and C. Chapman Serious hazards of transfusion annual report 2000-2001. The Serious Hazards of Transfusion Steering Group, Manchester, UK 2002 Available from: www.shotuk.org/SHOT%20report%2000-01.pdf
4. G. Andreu, P. Morel, and F. Forestier Hemovigilance network in France: Organization and analysis of immediate transfusion incident reports from 1994 to 1998 Transfusion 42 2002 1356 1364
5. M.J. Kuehnert, V.R. Roth, and N.R. Haley Transfusion-transmitted bacterial infection in the United States, 1998 through 2000 Transfusion 41 2001 1493 1499
6. P. Ness, H. Braine, and K. King Single-donor platelets reduce the risk of septic platelet transfusion reactions Transfusion 41 2001 857 861
7. J.P. AuBuchon, L.K. Cooper, and M.F. Leach Experience with universal bacterial culturing to detect contamination of apheresis platelet units in a hospital transfusion service Transfusion 42 2002 855 861
8. M. Goldman, J.-H. Lee, and M.A. Blajchman Skin antisepsis and initial aliquot diversion M.E. Brecker Bacterial and parasitic contamination of Blood Components 2003 AABB Press Bethesda, MD 31 56
9. M.A. Blajchman, M. Goldman, and F. Baeza Improving the bacterial safety of platelet transfusions Transfus. Med. Rev. 18 2004 11 24
10. M.E. Brecher, P.V. Holland, and A.A. Pineda Growth of bacteria in inoculated platelets: Implications for bacteria detection and the extension of platelet storage Transfusion 40 2000 1308 1312
11. M.E. Brecher, S.N. Hay, and S.J. Rothenberg Monitoring of apheresis platelet bacterial contamination with an automated liquid culture system: A university experience Transfusion 43 2003 974 978
12. D. de Korte, J.H. Marcelis, and A.J. Verhoeven Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections Vox Sang. 83 2002 13 16
13. H. Claeys, F. Logghe, and B. Vandekerchove Four-year experience with routine bacterial screening of platelet concentrates Transfus. Med. 1 2003 S326 (abstract, Suppl 1)
14. P.A.W. te Boeckhorst, E.A.M. Beckers, and M.C. Vos Clinical significance of bacteriologic screening in platelet concentrates Transfusion 45 2005 514 519
15. C.P. McDonald, S. Hartley, and K. Orchard Fatal Clostridium perfringens sepsis from a pooled platelet transfusion Transfus. Med. 8 1998 19 22
16. E.K.W. Chiu, K.Y. Yuen, and A.K.W. Lie A prospective study of symptomatic bacteremia following platelet transfusion and of its management Transfusion 34 1994 950 954
17. S. Wollowitz Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma Semin. Hematol. 38 2001 4 11 (4 Suppl 11)
18. V. Ciaravino, T. McCullough, and A.D. Dayan Pharmacokinetic and toxicology assessment of Intercept (S-59 and UVA treated) platelets Hum. Exp. Toxicol. 20 2001 533 550
19. V. Ciaravino Preclinical safety of a nucleic acid-targeted Helinx compound: A clinical perspective Semin. Hematol. 38 2001 12 19
20. D. van Rhenen, H. Gulliksson, and J.P. Cazenave Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: The euroSPRITE trial Blood 101 2003 2426 2433
21. J. McCullough, D.H. Vesole, and R.J. Benjamin Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: The SPRINT Trial Blood 104 2004 1534 1541
22. P.H. Ruane, R. Edrich, and D. Gamp Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light Transfusion 44 2004 877 885
23. L. Lin, R. Dikeman, and B. Molini Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria Transfusion 44 2004 1496 1504
24. L. Lin, C.V. Hanson, and H.J. Alter Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and UVA Transfusion 2005 (in press)
25. F. Knutson, R. Alfonso, and K. Dupuis Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function Vox Sang. 78 2000 209 216
26. L. Lin Inactivation of cytomegalovirus in platelet concentrates using Helinx technology Semin. Hematol. 38 2001 27 33 (4 Suppl 11)
27. W.C. van Voorhis, L.K. Barrett, and R.T. Eastman Trypanosoma cruzi inactivation in human platelet concentrates and plasma by psoralen (amotosalen HCl) and long-wavelength UV Antimicrob. Agents Chemother. 47 2003 475 479